
    
      DISCOVER is a NIS study to describe the disease management patterns and clinical evolution
      over three years in type 2 diabetes mellitus patients initiating a second line anti-diabetic
      treatment. This study is a multi-country, multicenter, observational, prospective,
      longitudinal cohort study. The patients will be recruitted from countries in Latin America,
      Europe and Asia pac. It is estimated that approximately 13350 patients will be enrolled in
      total with each patient followed up for 3 years.
    
  